CASE HISTORY – March 2022

Nivolumab – induced multi-organ failure: a case report

Authors: Anett Roosipuu, Elen Vettus, Riina Vettus

Articles PDF


Multi-organ failure is an uncommon but potentially fatal immune-related adverse event of immune checkpoint inhibitors (ICPis). As ICPis are increasingly used, the number of reports on immune-related adverse events (irAEs) has also increased. Management of severe irAEs is multidisciplinary, hence it is important to raise the awareness of irAEs.